FDA approves Keytruda/Padcev combo in advanced urothelial cancer
Record growth in U.S. life sciences real estate footprint
Pharma fees to European regulator spike thanks to 10% inflation rate
Diabesity drugs and their free ‘contract sales force’
*please scroll down for all the latest news*
